loading page

Polysorbate identity and quantity dictates the extensional flow properties of protein-excipient solutions
  • Kathleen Lauser,
  • Amy Rueter,
  • Michelle Calabrese
Kathleen Lauser
University of Minnesota Twin Cities

Corresponding Author:[email protected]

Author Profile
Amy Rueter
University of Minnesota Twin Cities
Author Profile
Michelle Calabrese
University of Minnesota Twin Cities
Author Profile

Abstract

While protein medications are promising for treatment of cancer and autoimmune diseases, challenges persist in terms of development and injection stability of high-concentration formulations. Here, the extensional flow properties of protein-excipient solutions are examined via dripping-onto-substrate (DoS) extensional rheology, using a model ovalbumin protein (OVA) and biocompatible excipients polysorbate 20 (PS20) and 80 (PS80). Despite similar PS structures, differences in extensional flow are observed based on PS identity in two regimes: at moderate total solution concentrations where surface tension differences drive changes in extensional flow behavior, and at small PS:OVA ratios, which impacts the onset of weakly elastic behavior. Undesirable elasticity is observed in ultra-concentrated formulations, independent of PS identity; higher PS contents are required to observe these effects than with analogous polymeric excipient solutions. These studies reveal novel extensional flow behaviors in protein-excipient solutions, and provide a straightforward methodology for assessing the extensional flow stability of new protein-excipient formulations.
16 May 2022Submitted to AIChE Journal
20 May 2022Submission Checks Completed
20 May 2022Assigned to Editor
27 May 2022Reviewer(s) Assigned
16 Jun 2022Editorial Decision: Revise Minor
24 Jun 20221st Revision Received
29 Jun 2022Submission Checks Completed
29 Jun 2022Assigned to Editor
16 Jul 2022Editorial Decision: Accept
04 Aug 2022Published in AIChE Journal. 10.1002/aic.17850